LONDON - As the race for the $1,000 genome heats up, Oxford NanoLabs Ltd., one of the leading European contenders, raised £10 million (US$19.89 million) in a second private round, enabling the company to develop working prototypes of its nanopore-based DNA sequencing technology. (BioWorld International) Read More
